Testosterone Clinical Trials

12 recruitingLast updated: May 13, 2026

There are 12 actively recruiting testosterone clinical trials across 12 countries. Studies span Phase 3, Phase 2, Phase 4, Not Applicable. Top locations include New York, New York, United States, Jacksonville, Florida, United States, Albemarle, North Carolina, United States. Updated daily from ClinicalTrials.gov.


Testosterone Trials at a Glance

12 actively recruiting trials for testosterone are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 3 with 4 trials, with the heaviest enrollment activity in New York, Jacksonville, and Albemarle. Lead sponsors running testosterone studies include Craig Hospital, Department of Endocrinology, St Vincent's Hospital, and Canisius-Wilhelmina Hospital.

Browse testosterone trials by phase

Treatments under study

About Testosterone Clinical Trials

Looking for clinical trials for Testosterone? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Testosterone trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Testosterone clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 2

TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Erectile Dysfunction Due to Arterial DiseaseEndothelial DysfunctionErectile Disfunction+3 more
Lomonosov Moscow State University Medical Research and Educational Center150 enrolled1 locationNCT07460960
Recruiting
Phase 3

Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)

MenopauseTestosterone DeficiencyEstrogen Deficiency
University of Sao Paulo General Hospital140 enrolled1 locationNCT06343870
Recruiting
Not Applicable

Evaluating Heart & Soil's Whole Package on Men's Health

Testosterone
Efforia, Inc100 enrolled1 locationNCT07256639
Recruiting

Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury

Testosterone DeficiencyEndothelial DysfunctionSpinal Cord Injuries
Craig Hospital48 enrolled1 locationNCT07227740
Recruiting
Phase 3

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Stage IV Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8+2 more
SWOG Cancer Research Network1,273 enrolled338 locationsNCT03678025
Recruiting

Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males

TestosteroneAngiographic ComplexityCoronary Lesion+2 more
Sohag University50 enrolled1 locationNCT07076771
Recruiting
Phase 3

Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

Prostatic NeoplasmsHypogonadismTestosterone Deficiency
Canisius-Wilhelmina Hospital140 enrolled10 locationsNCT04833426
Recruiting
Phase 2

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Central Nervous System DiseasesGenital Diseases, MaleHypogonadism+17 more
North Florida Foundation for Research and Education21 enrolled2 locationsNCT04460872
Recruiting

Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes

Hypogonadism, MaleTestosterone DeficiencyGonadal Dysfunction+3 more
Jumeirah American Clinic60 enrolled1 locationNCT06841328
Recruiting

New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.

Pelvic PainTestosteroneTransgender Persons+1 more
University Hospital, Grenoble15 enrolled1 locationNCT06487754
Recruiting
Phase 4

Metabolic effects of oestrogen compounds in men with low testosterone

Metabolic effects in men with low testosterone
Department of Endocrinology, St Vincent's Hospital24 enrolled1 locationACTRN12608000537358
Recruiting
Phase 3Phase 4

Testosterone in Obese Men Trial

Testosterone deficiency in ageing malesObese Middle-Aged and Older Men with Borderline Androgen Deficiency
PHIMR40 enrolled1 locationACTRN12605000283673